Used in research settings as a selective inhibitor for studying kinase signaling pathways, particularly in oncology-related studies. Shows potential in modulating cellular proliferation and apoptosis in tumor cell lines. Investigated for its role in enhancing the efficacy of other anticancer agents through pathway-specific suppression. Not approved for clinical use; currently limited to in vitro and preclinical experimentation.